Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (1633)	12/18/2005 10:41:15 PM
From: sammaster	Read Replies (1) \| Respond to of 1826

thanks for the reply.. i agree that more hospitals will use aloxi over zofran next year since the price differential will not be that great and aloxi is a better drug...what he did not say is that 2007 will bring generic zofran and much greater cost differential so hospitals will be quick to drop aloxi since zofran is not a "bad" drug.. hospitals are governed by profit margins if one drug is not clearly much more superior to another. clinics on the other hand will continue to use aloxi not just for the profit margins to the clinic but because it is a better drug also, since the cost of better care does not come out of their own pocket like it does for hospitals